SE9902155L - Serum antibodies - Google Patents

Serum antibodies

Info

Publication number
SE9902155L
SE9902155L SE9902155A SE9902155A SE9902155L SE 9902155 L SE9902155 L SE 9902155L SE 9902155 A SE9902155 A SE 9902155A SE 9902155 A SE9902155 A SE 9902155A SE 9902155 L SE9902155 L SE 9902155L
Authority
SE
Sweden
Prior art keywords
antibody
well
nucleus pulposus
pulposus cells
antibodies
Prior art date
Application number
SE9902155A
Other languages
Unknown language ( )
English (en)
Other versions
SE9902155D0 (sv
Inventor
Bjoern Rydevik
Kjell Olmarker
Original Assignee
Bjoern Rydevik
Kjell Olmarker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bjoern Rydevik, Kjell Olmarker filed Critical Bjoern Rydevik
Priority to SE9902155A priority Critical patent/SE9902155L/sv
Publication of SE9902155D0 publication Critical patent/SE9902155D0/sv
Priority to PCT/SE2000/001179 priority patent/WO2000075659A1/en
Priority to AU54373/00A priority patent/AU5437300A/en
Publication of SE9902155L publication Critical patent/SE9902155L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE9902155A 1999-06-09 1999-06-09 Serum antibodies SE9902155L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9902155A SE9902155L (sv) 1999-06-09 1999-06-09 Serum antibodies
PCT/SE2000/001179 WO2000075659A1 (en) 1999-06-09 2000-06-07 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment
AU54373/00A AU5437300A (en) 1999-06-09 2000-06-07 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902155A SE9902155L (sv) 1999-06-09 1999-06-09 Serum antibodies

Publications (2)

Publication Number Publication Date
SE9902155D0 SE9902155D0 (sv) 1999-06-09
SE9902155L true SE9902155L (sv) 2000-12-10

Family

ID=20415987

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902155A SE9902155L (sv) 1999-06-09 1999-06-09 Serum antibodies

Country Status (3)

Country Link
AU (1) AU5437300A (sv)
SE (1) SE9902155L (sv)
WO (1) WO2000075659A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60033055D1 (de) 1999-12-06 2007-03-08 Warsaw Orthopedic Inc Bandscheibenbehandlungsvorrichtung
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
CN100394989C (zh) 2002-11-15 2008-06-18 华沙整形外科股份有限公司 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
CA3019751A1 (en) * 2016-04-04 2017-10-12 Gu Ventures Ab Methods and compositions for the treatment of intervertebral disc herniation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
KR0185747B1 (ko) * 1989-12-20 1999-05-01 마리아 아이. 마마리노스 자기항원의 에어로졸 투여에 의한 자기면역질환의 개선된 치료방법
CA2148132A1 (en) * 1992-12-04 1994-06-23 Anthony Robin Poole Immunoassay for the measurement of collagen cleavage in cartilage
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
AUPO571297A0 (en) * 1997-03-19 1997-04-10 Montech Medical Developments Pty Ltd Method for the diagnosis of rheumatoid arthritis

Also Published As

Publication number Publication date
AU5437300A (en) 2000-12-28
WO2000075659A1 (en) 2000-12-14
SE9902155D0 (sv) 1999-06-09

Similar Documents

Publication Publication Date Title
NO981745D0 (no) Monoklonalt antistoff BR110 og anvendelse av dette
ATE213837T1 (de) Polypeptid-dendrimer komplexe
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
DE69503903D1 (de) Positive und positive/negative zellselektion vermittelt durch peptiofreisetzung
RS50477B (sr) Anti-il-12 antitela, kompozicije, metode i njihove upotrebe
DE69814052D1 (de) Automatische immunoassay kassette
CA2406240A1 (en) Hcv anti-core monoclonal antibodies
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
EP0420913A4 (en) Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
MX347883B (es) Anticuerpo monoclonal ds6, antigeno ca6 asociado con tumor, y metodos de uso de los mismos.
EP1579222B8 (en) Non-competitive immunoassay for small analytes
EP0847452A4 (en) FLUORESCENCE RESONANT ENERGY TRANSFER DETERMINATION METHOD FOR IDENTIFYING THE HIV-1 ENVELOPE GLYCOPROTEIN CELL
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
CA2348026A1 (en) Antibodies against semp1, methods for their production and uses thereof
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
SE9902155L (sv) Serum antibodies
FI922017A0 (fi) Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa.
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
WO2005020891A3 (en) Monoclonal antibodies against ricin toxin and methods of making and using thereof
EA200100287A1 (ru) Высокоаффинные антитела
GB8827347D0 (en) Determination method use & components
AU2001250470A1 (en) Novel antibodies specifically identifying inactive psa, and uses thereof
BR0204612A (pt) Anticorpos monoclonais antinúcleo de hcv

Legal Events

Date Code Title Description
NAV Patent application has lapsed